Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
0.00%
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Atuzaginstat (COR388) / Lysine gingipain inhibitor Details Alzheimer's disease, Neurological disorder | Failed Discontinued | |
COR588 (Lysine gingipain inhibitor) Details Mental health, Alzheimer's disease, Neurological disorder | Failed Discontinued | |
Atuzaginstat (COR388) (Lysine gingipain inhibitor) Details Periodontal disease | Failed Discontinued | |
Atuzaginstat (COR388) / Lysine gingipain inhibitor Details Parkinson's disease | Failed Discontinued |